This inventor holds 6 USPTO granted patents, plus 3 CIPO patents and 1 EPO patent. Top assignee: National Research Council of Canada. Active years: 2001-2023.
Location History:
- Montréal, CA (2001 - 2010)
- Montreal, CA (2018 - 2023)
Company Filing History:
Years Active: 2001-2023
Title: Amine A Kamen: Innovator in Antibody Research and Protein Production
Introduction
Amine A Kamen is a prominent inventor based in Montréal, Canada. He has made significant contributions to the fields of antibody research and recombinant protein production. With a total of 6 patents to his name, Kamen's work has had a substantial impact on biotechnology and medical research.
Latest Patents
Kamen's latest patents include innovative developments in hemagglutinin-specific antibodies. These antibodies are designed to recognize antigens from multiple influenza strains, providing potential advancements in vaccine development and therapeutic applications. Another notable patent focuses on enhancing the production of recombinant proteins through a novel process involving transient transfection of suspension-growing mammalian cells. This method allows for high expression levels of proteins in a scalable and efficient manner, making it suitable for high-throughput production.
Career Highlights
Amine A Kamen is affiliated with the National Research Council of Canada, where he has been instrumental in advancing research in his field. His expertise in antibody development and protein expression has positioned him as a leader in biotechnology innovation. Kamen's work not only contributes to scientific knowledge but also has practical applications in medicine and industry.
Collaborations
Throughout his career, Kamen has collaborated with esteemed colleagues such as Sylvie Perret and Phuong Lan Pham. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.
Conclusion
Amine A Kamen's contributions to antibody research and recombinant protein production exemplify the spirit of innovation in biotechnology. His patents and collaborative efforts continue to influence the field, paving the way for future advancements.